Adolescent cannabinoid exposure caused lasting sleep changes into adulthood in rats
Rats exposed to a cannabinoid receptor agonist during adolescence showed persistent sleep disturbances in adulthood, including decreased wakefulness and increased REM sleep.
Quick Facts
What This Study Found
Adolescent rats exposed to WIN 55,212-2 (a cannabinoid agonist) for 14 days during adolescence (postnatal days 30-44) showed significant sleep disturbances when tested as adults (postnatal day 80): decreased wakefulness and enhanced REM sleep. Brain analysis revealed increased neuronal markers in the dorsomedial hypothalamic nucleus, a sleep-regulating region.
Key Numbers
Exposure: postnatal days 30-44; testing: postnatal day 80; decreased wakefulness and increased REM sleep persisted ~5 weeks after exposure ended; increased NeuN in dorsomedial hypothalamic nucleus.
How They Did This
Animal study exposing adolescent rats to cannabinoid agonist WIN 55,212-2 (0.1-1.0 mg/kg/day IP) for 14 days during adolescence, with sleep recording and NeuN immunohistochemistry in adulthood.
Why This Research Matters
Cannabis use is common during adolescence, when the brain is still developing. This study shows that cannabinoid exposure during this critical window can permanently alter sleep architecture.
The Bigger Picture
Sleep problems are among the most common complaints of both current cannabis users and those who have quit. This animal study suggests that adolescent use may create lasting changes to sleep circuitry that persist even after stopping.
What This Study Doesn't Tell Us
Animal study using a synthetic cannabinoid agonist (not THC); rat adolescence is a rough analog for human adolescence; only male rats studied; electrophysiological sleep recording has limitations.
Questions This Raises
- ?Do these sleep changes persist into old age?
- ?Would CBD or lower-THC cannabis produce the same lasting effects?
Trust & Context
- Key Stat:
- Sleep disruption persisted 5+ weeks after adolescent cannabinoid exposure ended
- Evidence Grade:
- Preliminary: animal study with synthetic compound; cannot directly translate to human adolescent cannabis use.
- Study Age:
- Published 2020.
- Original Title:
- Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood.
- Published In:
- European journal of pharmacology, 874, 172911 (2020)
- Authors:
- Macías-Triana, Lorena, Romero-Cordero, Karen, Tatum-Kuri, Agnes, Vera-Barrón, Alba, Millán-Aldaco, Diana, Arankowsky-Sandoval, Gloria, Piomelli, Daniele, Murillo-Rodríguez, Eric
- Database ID:
- RTHC-02702
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can teenage cannabis use permanently affect sleep?
In this animal model, cannabinoid exposure during adolescence caused lasting sleep changes that persisted into adulthood. Human studies are needed to confirm whether this translates to people.
What kind of sleep changes occurred?
Adult rats who were exposed during adolescence showed decreased wakefulness and increased REM sleep, along with changes in a brain region that regulates the sleep-wake cycle.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-02702APA
Macías-Triana, Lorena; Romero-Cordero, Karen; Tatum-Kuri, Agnes; Vera-Barrón, Alba; Millán-Aldaco, Diana; Arankowsky-Sandoval, Gloria; Piomelli, Daniele; Murillo-Rodríguez, Eric. (2020). Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood.. European journal of pharmacology, 874, 172911. https://doi.org/10.1016/j.ejphar.2020.172911
MLA
Macías-Triana, Lorena, et al. "Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood.." European journal of pharmacology, 2020. https://doi.org/10.1016/j.ejphar.2020.172911
RethinkTHC
RethinkTHC Research Database. "Exposure to the cannabinoid agonist WIN 55, 212-2 in adolesc..." RTHC-02702. Retrieved from https://rethinkthc.com/research/macias-triana-2020-exposure-to-the-cannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.